Τόμος 26 (2008) – Τεύχος 2 – Άρθρο 1 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 26 (2008) – Issue 2– Article 1 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Θεοφάνης Βαβίλης, Νικόλ Μασουρίδου, Ελένη Φράγκου

Εργαστήριο Γενικής Βιολογίας, Ιατρική Σχολή, Αριστοτέλειο Πανεπιστήμιο, Θεσσαλονίκη, Ελλάς

Theophanis Vavilis, Nicole Masouridou, Helen Frangou

Department of General Biology, Medical School, Aristotle University, Thessaloniki, Greece

2. Lodish H., Berk A., Matsudaira P., Kaiser C.A., Krieger M., Scott M.P., Zipursky S.L., Darnell J.: Molecular Cell Biology. 5th ed. Pp. 447-491, W. H. Freeman and Company, New York, 2004

3. Pasternak J.J.: An Introduction to Human Molecular Genetics, Mechanisms of Inherited Diseases. 2nd ed. Pp. 208-213, Fitzgerald Science Press, University of Waterloo, Canada, 1999

4. Johnson N., Speirs V., Curtin N.J., Hall A.G.: A comparative study of genome-wide SNP, CGH microarray and protein expression analysis to explore genotypic and phenotypic mechanisms of acquired antiestrogen resistance in breast cancer. Breast Cancer Res. Treat. 2007 Sep 28 [Epub ahead of print]

5. Βlomberg K.E., Smith C.I., Lindvall J.M.: Gene expression signatures in primary immunodeficiencies: the experience from human disease and mouse models. Curr. Mol. Med. 6: 555-566 (2007)

6. Walker EJ, Siminovitch KA. Primer: genomic and proteomic tools for the molecular dissection of disease. Nat. Clin. Pract. Rheumatol. 3: 580-589 (2007)

7. Komar A.A.: SNPs, Silent But Not Invisible. Science 315: 466-467 (2007)

8. Κimchi-Sarfaty C., Oh J.M., Kim I.-W., Sauna Z.E., Calcagno A.M., Ambudkar S.V., Gottesman M.M.: A “silent” Polymorphism in the MDR1 Gene Changes Substrate Specificity. Science 315: 525-528 (2007)

9. Εbbert M.T., Beckstead W.A., O΄Connor T.D., Clement M.J., McClellan D.A.: Pharmacogenomics: analyzing SNPs in the CYP2D6 gene using amino acid properties. Int. J. Bioinform. Res. Appl. 3: 471-479 (2007)

10. Chen H., Ordog T., Chen J., Young D.L., Bardsley M.R., Redelman D., Ward S.M., Sanders K.M.: Differential gene expression in functional classes of interstitial cells of Cajal in murine small intestine. Physiol. Genomics 31: 492-509 (2007)

11. Soikkeli J., Lukk M., Nummela P., Virolainen S., Jahkola T., Katainen R., Harju L., Ukkonen E., Saksela O., Holtta E.: Systemic search for the best gene expression markers for melanoma micrometastasis detection. J. Pathol. 213: 180-189 (2007)

12. Βensemain F., Hot D., Ferreira S., Dumont J., Bombois S., Maurage C.A., Huot L., Hermant X., Levillain E., Hubans C., Hansmannel F., Chapuis J., Hauw J.J., Schraen S., Lemoine Y., Buee L., Berr C., Mann D., Pasquier F., Amouyel P., Lambert J.C.: Evidence for induction of the ornithine transcarbamylase expression in Alzheimer΄s disease. Mol. Psychiatry (2007) [Epub ahead of print]

13. Balada E.. Ordi-Ros J., Vilardell-Tarres M.: DNA methylation and systemic lupus erythematosus. Ann. N.Y. Acad Sci. 1108: 127-136 (2007)

14. Clark D.: Molecular Biology. Pp. 291-297, Elsevier Academic Press, London, UK, 2005

15. Blenkiron C., Miska E.A.: miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum. Mol. Genet. 16(Spec.1): R106-113 (2007)

16. Clark S.J.: Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. Hum. Mol. Genet. 16: R88-95 (2007)

17. Moriconi F., Raddatz D., Ho N.A., Yeruva S., Dudas J., Ramadori G.: Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor necrosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis. Trensl. Res. 150: 223-232 (2007)

18. Hopwood B., Tsykin A., Findlay D.M., Fazzalari N.L.: Microarray gene expression profiling of human osteoarthritic bone suggests altered bone remodeling, WNT and TGF beta/BMP signaling. Arthritis Res. Ther. 9(5): R100 (2007)

19. Varghese S., Burness M., Xu H., Beresnev T., Pingpank J., Alexander H.R.: Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum. Ann. Surg. Oncol. 14: 3460-3471 (2007)

20. Woodruff P.G., Boushey H.A., Dolganov G.M., Barker C.S., Yang Y.H., Donnelly S., Ellwanger A., Sidhu S.S., Dao-Pick T.P., Pantoja C., Erle D.J., Yamamoto K.R., Fahy J.V.: Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc. Natl. Acad. Sci. USA 104: 15858-15863 (2007)

21. Duong C., Greenawalt D.M., Kowalczyk A., Ciavarella M.L., Raskutti G., MURRAY W.K., Phillips W.A., Thomas R.J.: Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer. Ann. Surg. Oncol. 14: 3602-3609 (2007)

22. Yu A.M.: Small interfering RNA in drug metabolism and transport. Curr. Drug Metab. 8: 700-708 (2007)

23. Marguerite V.E., Beri-Dexheimer M.E., Ortiou S., Gu Facute Ant J.L., Merten M.: Cobalamin potentiates vinblastine cytotoxicity through downregulation of mdr-1 gene expression in HepG2 cells. Cell Physiol. Biochem. 20: 967-976 (2007)

24. Holloway A.F., Oakford P.C.: Targeting epigenetic modifiers in cancer. Curr. Med. Chem. 14: 2540-2547 (2007)

25. Βronner C., Chataigneau T., Schini-Kerth V.B., Landry Y.: The Epigenetic Code Replication Machinery, ECREM : a promising drugable target of the epigenetic cell memory. Curr. Med. Chem. 14: 2629-2641 (2007)

26. Oscarson M., Βurk O., Winter S., Schwab M., Wolbold R., Dippon J., Eichelbaum M., Meyer U.A.: Effects of rifambicin on global gene expression in human small intestine. Pharmacogenet. Genomics 17: 907-918 (2007)

27. Whittaker S.R., Te Poele R.H., Chan F., Linardopoulos S., Walton M.I., Garrett M.D., Workman P.: The cyclin-dependent kinase inhibitor seliciclib (R-roscovitine; CYC202) decreases the expression of mitotic control genes and prevents entry into mitosis. Cell Cycle 6: 113-131 (2007)

28. Valvason C., Musacchio E., Pozzuoli A., Ramonda R., Aldegheri R., Punzi L.: Rheumatology (Oxford) 47(1): 31-35 (2008)

29. Donati A., Ventruti A., Cavallini G., Masini M., Vittorini S., Chantret I., Codogno P., Bergamini E.: In vivo effect of an antilipolytic drug (3,5΄-dimethylpvyrazole) on autophagic proteolysis and autophagy-related gene expression in rat liver. Biochem. Biophys. Res. Commun. 366: 686-792 (2008)

30. Yu C., Kastin A.J., Tu H., Waters S., Pan W.: TNF activates P-glycoprotein in cerebral microvascular endothelial cells. Cell Physiol. Biochem. 20: 853-858 (2007)

31. Mund C., Brueckner B., Lyko F.: Reactivation of epigenetically silenced genes by DANN methyltransferase inhibitors: basic concepts and clinical applications. Epigenetics 1: 7-13 (2006)

32. Martinez R., Schackert G.: Epigenetic aberrations in malignant gliomas: an open door leading to better understanding and treatment. Epigenetics 2: 147-150 (2007)

33. Liu T., Tee A.E., Porro A., Smith S.A., Dwarte T., Liu P.Y., Iraci N., Sekyere E., Haber M., Norris M.D., Diolaiti D., Della Valle G., Perini G., Marshall G.M.: Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis. Proc. Natl. Acad. Sci. USA 104: 18682-18687 (2007)